BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 7586598)

  • 21. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
    Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diurnal variation of sex hormone binding globulin and insulin-like growth factor binding protein-1 in women with polycystic ovary syndrome.
    Hamilton-Fairley D; White D; Griffiths M; Anyaoku V; Koistinen R; Seppälä M; Franks S
    Clin Endocrinol (Oxf); 1995 Aug; 43(2):159-65. PubMed ID: 7554310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum total renin is elevated in women with polycystic ovarian syndrome.
    Jaatinen TA; Matinlauri I; Anttila L; Koskinen P; Erkkola R; Irjala K
    Fertil Steril; 1995 May; 63(5):1000-4. PubMed ID: 7720907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are circulating leptin and luteinizing hormone synchronized in patients with polycystic ovary syndrome?
    Sir-Petermann T; Piwonka V; Pérez F; Maliqueo M; Recabarren SE; Wildt L
    Hum Reprod; 1999 Jun; 14(6):1435-9. PubMed ID: 10357954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The synergistic effect of sex hormone-binding globulin and aromatase genes on polycystic ovary syndrome phenotype.
    Xita N; Georgiou I; Lazaros L; Psofaki V; Kolios G; Tsatsoulis A
    Eur J Endocrinol; 2008 Jun; 158(6):861-5. PubMed ID: 18505907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between genes encoding components of the Leutinizing hormone/Luteinizing hormone-choriogonadotrophin receptor pathway and polycystic ovary syndrome in Egyptian women.
    El-Shal AS; Zidan HE; Rashad NM; Abdelaziz AM; Harira MM
    IUBMB Life; 2016 Jan; 68(1):23-36. PubMed ID: 26662070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome.
    Taylor AE; McCourt B; Martin KA; Anderson EJ; Adams JM; Schoenfeld D; Hall JE
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2248-56. PubMed ID: 9215302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome.
    Baranowska B; Radzikowska M; Wasilewska-Dziubińska E; Kapliński A; Roguski K; Płonowski A
    Gynecol Endocrinol; 1999 Oct; 13(5):344-51. PubMed ID: 10599552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reproductive hormone levels and anthropometry in postmenopausal women with polycystic ovary syndrome (PCOS): a 21-year follow-up study of women diagnosed with PCOS around 50 years ago and their age-matched controls.
    Schmidt J; Brännström M; Landin-Wilhelmsen K; Dahlgren E
    J Clin Endocrinol Metab; 2011 Jul; 96(7):2178-85. PubMed ID: 21508129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Free testosterone, luteinizing hormone/follicle stimulating hormone ratio and pelvic sonography in relation to skin manifestations in patients with polycystic ovary syndrome.
    Sharquie KE; Al-Bayatti AA; Al-Ajeel AI; Al-Bahar AJ; Al-Nuaimy AA
    Saudi Med J; 2007 Jul; 28(7):1039-43. PubMed ID: 17603706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.
    Eagleson CA; Gingrich MB; Pastor CL; Arora TK; Burt CM; Evans WS; Marshall JC
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4047-52. PubMed ID: 11095431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between the prevalence of hyperuricemia and reproductive hormones in polycystic ovary syndrome.
    Mu L; Pan J; Yang L; Chen Q; Chen Y; Teng Y; Wang P; Tang R; Huang X; Chen X; Yang H
    Reprod Biol Endocrinol; 2018 Oct; 16(1):104. PubMed ID: 30359269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of different ranges of LH:FSH ratios in polycystic ovarian syndrome (PCOS) - Clinical based case control study.
    Malini NA; Roy George K
    Gen Comp Endocrinol; 2018 May; 260():51-57. PubMed ID: 29273352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of luteinizing hormone-beta gene polymorphism in the onset and progression of puberty in healthy boys.
    Raivio T; Huhtaniemi I; Anttila R; Siimes MA; Hagenäs L; Nilsson C; Pettersson K; Dunkel L
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3278-82. PubMed ID: 8784083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum leptin as an additional possible pathogenic factor in polycystic ovary syndrome.
    El Orabi H; Ghalia AA; Khalifa A; Mahfouz H; El Shalkani A; Shoieb N
    Clin Biochem; 1999 Feb; 32(1):71-5. PubMed ID: 10074895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship of GnRH-stimulated LH release to episodic LH secretion and baseline endocrine-metabolic measures in women with polycystic ovary syndrome.
    Patel K; Coffler MS; Dahan MH; Malcom PJ; Deutsch R; Chang RJ
    Clin Endocrinol (Oxf); 2004 Jan; 60(1):67-74. PubMed ID: 14678290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases.
    Kiddy DS; Sharp PS; White DM; Scanlon MF; Mason HD; Bray CS; Polson DW; Reed MJ; Franks S
    Clin Endocrinol (Oxf); 1990 Feb; 32(2):213-20. PubMed ID: 2112067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome.
    Fenkci SM; Fenkci V; Oztekin O; Rota S; Karagenc N
    Hum Reprod; 2008 Jul; 23(7):1602-6. PubMed ID: 18378560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of D327N sex hormone-binding globulin gene polymorphism in the pathogenesis of polycystic ovary syndrome.
    Bendlová B; Zavadilová J; Vanková M; Vejrazková D; Lukásová P; Vcelák J; Hill M; Cibula D; Vondra K; Stárka L; Vrbíková J
    J Steroid Biochem Mol Biol; 2007 Apr; 104(1-2):68-74. PubMed ID: 17258903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.